InMed Pharmaceuticals Inc

NASDAQ:INM   10:50:42 AM EDT
0.81
+0.05 (+6.58%)
Earnings Announcements

InMed Pharmaceuticals Reports Q3 Net Loss Per Share Of $0.25

Published: 05/13/2022 11:51 GMT
InMed Pharmaceuticals Inc (INM) - Inmed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update.
Inmed Pharmaceuticals Inc - Qtrly Net Loss per Share $0.25.
Revenue is expected to be $0.75 Million
Adjusted EPS is expected to be -$0.22

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.